ISSN 1662-4009 (online)

ey0018.13-2 | Diabetes | ESPEYB18

13.2. Worldwide differences in childhood type 1 diabetes: The SWEET experience

M Saiyed , D Hasnani , GT Alonso , E Richmond , S Besancon , A Cotterill , U Ngwu , C Mazza , D Rottenbourg , S Lanzinger

Pediatr Diabetes 2020;1–8. doi: 10.1111/pedi.13137– As part of the SWEET initiative, the authors analyzed the clinical characteristics of 26,726 individuals with type 1 diabetes (T1D) aged < 21 years living in Europe, Asia/Middle East/Africa, Australia/New Zealand, North America and South America– Among patient care indicators, the percent of HbA1c < 7.5% ranged between r...

ey0021.11-3 | Interventions for Weight Loss: New Findings | ESPEYB21

11.3. Who benefits most from outpatient lifestyle intervention? an IMI-SOPHIA study on pediatric individuals living with overweight and obesity

N Prinz , H Pomares-Millan , A Dannemann , GN Giordano , C Joisten , A Korner , D Weghuber , S Weihrauch-Bluher , S Wiegand , RW Holl , S Lanzinger

Brief Summary: For both clinicians and patients, it is of great interest to have easily-applicable predictors to forecast weight reductions achievable by lifestyle intervention (LI). This study identified 3 distinct clusters of responses to paediatric outpatient LI. Up to 2 years after LI initiation, responses ranged from ‘pronounced BMIz loss’ (in 19% of patients; median delta-BMIz: -0.61 (IQR: -0.76 to -0.49) to ‘moderate BMIz loss’ (in 45%; -0.23 (-0.33 ...